Company: DHR
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0000313616-25-000182
Chunk: 9

Company: DANAHER CORP /DE/
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 1
Chunk 9
---
oring in the effect of rounding to the nearest cent per share, the sum of prior quarterly EPS figures may not equal year-to-date EPS.Information related to the calculation of net earnings per common share is summarized as follows ($ and shares in millions, except per share amounts):Three-Month Period EndedNine-Month Period EndedSeptember 26, 2025September 27, 2024September 26, 2025September 27, 2024Numerator:Net earnings $908 $818 $2,417 $2,813 Denominator:Weighted average common shares outstanding used in Basic EPS710.7 723.0 714.5 733.8 Incremental common shares from:Assumed exercise of dilutive options and vesting of dilutive restricted stock units (“RSUs”) and performance stock units (“PSUs”)3.0 6.4 3.4 6.3 Weighted average common shares outstanding used in Diluted EPS713.7 729.4 717.9 740.1 Basic EPS $1.28 $1.13 $3.38 $3.83 Diluted EPS $1.27 $1.12 $3.37 $3.80 

8

NOTE 4.  REVENUE

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 26, 2025 and September 27, 2024 ($ in millions).  Sales taxes and other usage-based taxes collected from customers are excluded from revenue.BiotechnologyLife SciencesDiagnosticsTotalFor the Three-Month Period Ended September 26, 2025:Geographical region:North America(a)$624 $728 $1,228 $2,580 Western Europe587 392 417 1,396 Other developed markets(b)89 130 97 316 High-growth markets(c)498 542 721 1,761 Total$1,798 $1,792 $2,463 $6,053 Revenue type:Recurring$1,590 $1,216 $2,211 $5,017 Nonrecurring208 576 252 1,036 Total$1,798 $1,792 $2,463 $6,053 For the Three-Month Period Ended September 27,